ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Personalised Health Supplements Customised from Genetic Screening Results Offered on airasia Super App

PETALING JAYA, Malaysia, Apr 6, 2022 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical company, is pleased to announce the launch of its genetic screening plus personalised health supplements solutions on the airasia Super App, the region's leading travel & lifestyle digital platform.

Besides airasia Super App, this unique collaboration also includes Speedoc, a virtual clinic and healthcare solutions platform that will provide consultation of test results by their doctors, and MGRC partner Unique Remedy, compounding pharmacy specialist which will produce the personalised health supplements.

All genetic screening solutions include the Dtect Wellness genetic screening test complemented with personalised supplements made based on each person's test results. The Dtect Wellness test analyses a person's DNA to identify relevant genetic markers that play important roles in influencing nutrition, health and wellness. Based on the test results, supplements that are deemed most important for the particular person's health are identified, and personalised health supplements are produced.

Mr. Sasha Nordin, Chief Executive Officer of Malaysian Genomics, said, "We are delighted with this collaboration to bring our range of genetic screening solutions to the public. This is the first time Malaysian Genomics is offering genetic screening together with a health supplement solution. Genetic screening tests can give insights and indicate the risks for a large range of diseases and conditions that can affect health. The knowledge from genetic screening is important as people can use it to make changes in their lifestyle and diet to lead healthier lives. Personalised health supplements are among one of the actionable steps that can be quickly taken."

Encik Noor Azri bin Dato' Sri Noor Azerai (Azri Azerai), Executive Director of Malaysian Genomics, said, "This collaboration will be a start to a series of exciting products and services we are offering to expand Malaysian Genomics' suite of healthcare-related solutions that cater to different needs and groups as people become more aware of their health and want to know more as well as take action on how they can improve or enhance their health."

Mr. Vincent Gooi, Head of airasia health, airasia Super App, said, "Our Allstars and all the super app users' well-being are our priority, and we are excited to welcome the addition of Malaysia Genomic's genetic screening programme to our airasia health platform. It is very important that each of us have self-awareness and learn how to take care of ourselves before we serve others. The comprehensive test results from Dtect Wellness provide very useful information and even go into details of weight management, response towards nutrition and dietary supplements and susceptibility towards injuries related to physical activities."

Besides Dtect Wellness, other tests can be added to the solutions, including Dtect Onco that screens for hereditary cancer risks, Dtect Cardio & Metabolic, which screens for cardiovascular and metabolic diseases and, Dtect PGx, which screens for risk of adverse reactions and response to prescription medications.

These genetic screening test solutions are available for purchase on AirAsia's The Asean Super App.

Malaysian Genomics Resource Centre Berhad: http://www.mgrc.com.my/
Malaysian Genomics Resource Centre Berhad: 0155 / [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK]

Source: Malaysian Genomics Resource Centre BerhadAirAsia

Copyright 2022 ACN Newswire . All rights reserved.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.